ArticleEuropean journal of heart failure2022

Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC).

Rudolf A de Boer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.